Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Beluga Health vs BiltRx

Beluga Health
Graded #431

Lower grade

vs+19.200000000000003
BiltRx
Graded #60

Higher grade

The verdict

BiltRx takes it — 75/100 to 55.8/100.

BiltRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. BiltRx is a US health-optimization telehealth platform spanning men's health, women's health, aesthetics and weight loss that offers compounded and brand-name GLP-1 medications.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBiltRx +45
45
90
Dose & formulationBiltRx +45
40
85
Clinical oversightBeluga Health +2
76
74
Labs & monitoringBeluga Health +10
62
52
FulfillmentBiltRx +7
64
71
Contract termsEven
55
55
Beluga Health · left barBiltRx · right bar

The numbers

MetricBeluga HealthBiltRx
WeighScore55.8/10075/100
GradeCC
Scorecard rank#431#60
SemaglutideNot disclosed$125/mo (all doses, compounded)
TirzepatideNot disclosed$129/mo (all doses, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
Beluga Health

Graded #431 · C

Strengths

  • Supports GLP-1 care with compounded semaglutide and tirzepatide
  • Board-certified providers and a 50-state medical infrastructure
  • LegitScript certified with SOC 2 and ISO 27001 security
  • Pharmacies follow FDA/USP standards with third-party batch testing
  • Powers many DTC brands as a turnkey telehealth backbone

Where it loses points

  • White-label B2B group, not a direct consumer-facing service
  • Offers compounded, not FDA-approved branded, GLP-1s
  • No public consumer pricing for the GLP-1 offering
  • Cited among nationwide groups tied to FDA telehealth GLP-1 scrutiny
  • Care quality varies by the consumer brand using the platform
BiltRx

Graded #60 · C

Strengths

  • Very low starting prices (semaglutide from 125 dollars, tirzepatide from 129 dollars)
  • LegitScript verified and HIPAA compliant
  • Names its 503A compounding pharmacies (Boothwyn and Southend)
  • Offers both compounded and brand-name GLP-1 options

Where it loses points

  • Covered states are behind a check-availability gate, not listed
  • Starting prices may rise depending on plan and dose

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard